Bringing a drug to market already takes long enough. You can’t afford to waste critical time on inefficient processes like faxing and overnighting documents, which delay a patient’s access to the treatments you’re developing. That’s why 14 of the top 15 global pharmaceutical companies use Docudash to improve the efficiency of clinical, quality, and internal operations. From patient consents to vendor contracts, Docudash's eSignature solutions meet the needs of pharmaceutical organizations while supporting compliance with industry regulations like 21 CFR Part 11.
To serve a global patient population, you need to conduct trials and launch products in markets around the world. We’ve got you covered. Docudash is available in 44 languages, and we have invested more than $500 million into our product to support customer needs worldwide.
We work with industry experts to ensure our technology, people, and processes meet your security and compliance standards. Docudash supports compliance with 21 CFR Part 11, HIPAA, eIDAS and EMA regulations, and more. We have the industry’s strongest data encryption practices, with systems audited and certified against the most rigorous security certifications like ISO 27001, TRUSTe, PCI, and SSAE 16. It's no wonder Docudash is trusted by 14 of the top 15 global pharmaceutical companies.
We’ve worked hard to build relationships with life sciences industry partners like SAFE-BioPharma, Microsoft, Exostar, and USDM Life Sciences. Docudash integrates with key technologies and validation partners to help you meet compliance requirements and stay fully digital.
Docudash is used to complete documents, approvals and agreements in the pharmaceutical industry, including:
Docudash for Pharmaceuticals
Using Docudash to Facilitate Compliance with 21 CFR Part 11
